Through a combination of cytokines array, quantitative PCR, and ELISA assay, we confirmed that FGF2 was the key factor that facilitated the development of chemoresistance of prostate cancer cells co-cultured with endothelial cells. The gene discussed is FGF2; the disease is Familial prostate cancer.